NCT07461415

Brief Summary

The investigators propose an intervention that leverages the success of Community Healthcare Workers (CHWs) and telehealth to connect patients with severe hypertension from Emergency Department (ED) to primary care resources and to coach them to adopt evidence-based, practical lifestyle solutions relevant to urban living. The investigators have proposed this intervention as "Coaching and Navigation by Community Health Workers (CHWs) through Telehealth for High-risk Hypertension: CONNECT-HTN intervention. The investigators hypothesize that participants receiving the CONNECT-HTN intervention will have a lower likelihood of experiencing a major cardiac event compared with those referred to clinic-based care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,620

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
40mo left

Started Mar 2026

Typical duration for not_applicable hypertension

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Mar 2026Aug 2029

First Submitted

Initial submission to the registry

February 27, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 10, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

March 16, 2026

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2029

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3.4 years

First QC Date

February 27, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

Community Healthcare WorkersHypertensionTelehealthLow-middle-income country

Outcome Measures

Primary Outcomes (1)

  • Rate of Major Adverse Cardiac Events (MACE)

    Major Adverse Cardiovascular Events (MACE) is a composite outcome including heart attack (myocardial infarction), stroke, heart failure, and cardiovascular death. The primary outcome will be assessed by comparing the cumulative incidence of MACE events between participants randomized to the CONNECT-HTN intervention arm and those randomized to referral to clinic-based care. MACE events will be identified through participant interviews, hospital record review, death certificates during the outcome collection team visit and verbal autopsy when required, and adjudicated using standardized criteria.

    Up to 36 months (during the outcome collection period)

Secondary Outcomes (3)

  • Blood Pressure (SBP/DBP) Over Time

    Every 6 months during follow-up (up to 36 months)

  • Outpatient Primary Care Follow-up

    Up to 36 months

  • Medication Adherence (MMAS-8 Score)

    Every 6 months during the 36-month follow-up period.

Other Outcomes (2)

  • Proportion of outcome measurement team visits completed

    Once every 6 months during the 36 month follow-up period

  • Assessment of Participant Satisfaction using Telehealth Usability Questionnaire (Intervention group only)

    6 months; 12 months; 18 months; 24 months; 30 months

Study Arms (2)

Referral arm

ACTIVE COMPARATOR

In the referral arm, patients with hypertension will receive a digital BP monitor (an Omron device), a brief teaching session on its proper use, and an emergency medical services number for any medical concerns. A small outcomes team will visit their household within 3 months of their discharge from the Emergency Department (ED) to review their readings and ask a few more questions about their health. This outcome team will visit every 6 months for a total of five home visits to monitor their health.

Other: Standard ED management

T-CHW arm

EXPERIMENTAL

In the T-CHW arm, patients with hypertension will receive a digital BP monitor (an Omron device) and a brief teaching session on its proper use. They will also be connected with a Community Healthcare Worker (CHW) via a telephone number. The CHW will call them to ask about their health and counsel them on diet and exercise to support good blood pressure control. The CHW will call them every month at a mutually convenient time for up to 36 months. A small outcomes team will visit their household within 3 months of their discharge from the ED to review their readings and ask a few more questions about their health. This outcome team will visit every 6 months for a total of five home visits to monitor their health.

Behavioral: CONNECT-HTN

Interventions

CONNECT-HTNBEHAVIORAL

We propose a multimodal intervention that leverages the success of CHWs and telehealth to connect patients with severe hypertension to primary care resources and coach them to adopt evidence-based, practical lifestyle solutions relevant to urban living. We call the intervention Coaching and Navigation by CHW through Telehealth for High-risk Hypertension or CONNECT-HTN. CONNECT HTN will add to the evidential basis for implementing many of the WHO Best Buys for Non-Communicable Disease (NCD) prevention and control, and will be the first study powered to measure substantive mortality and mortality outcomes in LMICs.

T-CHW arm

During the Emergency Department (ED) admission, the participants in the control group will be provided a blood pressure measurement device and training to calculate their blood pressure at home. Standard ED management will be provided to these patients, followed by either discharge or admission for the management of hypertension.

Referral arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible patients
  • Must be over the age of 18 years
  • Have an ED triage SBP \> 180 and/or DBP \> 110, with a repeat similar reading ≥30 minutes after triage
  • May have received treatment for elevated BP, but must have no evidence of end-organ damage (acute stroke, acute coronary syndrome, acute kidney injury, or papilledema)
  • May be admitted for deranged BP only with no complications, or may be stable for discharge per treating emergency physician
  • Can provide informed consent. Intervention is accessible to individuals of all literacy levels
  • Can receive phone calls and in-person visits. Smartphone ownership not required (intervention compatible with analog phones)

You may not qualify if:

  • Given that hypertension is defined and treated differently, we will exclude
  • pregnant patients
  • terminally ill patients, as well as
  • those requiring admission to the hospital due to severe complications (other than deranged BP).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Aga Khan University Hospital (AKUH)

Karachi, Sindh, Pakistan

RECRUITING

Dow University of Health Sciences, Ojha Campus (DUHS)

Karachi, Pakistan

RECRUITING

Jinnah Postgraduate Medical Center (JPMC)

Karachi, Pakistan

RECRUITING

Sindh Institute of Emergency and Health Sciences (SIEHS)

Karachi, Pakistan

RECRUITING

Related Publications (18)

  • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5. Epub 2016 Nov 16.

    PMID: 27863813BACKGROUND
  • Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo AP, Hering D, Lopez-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016 Nov 26;388(10060):2665-2712. doi: 10.1016/S0140-6736(16)31134-5. Epub 2016 Sep 23. No abstract available.

    PMID: 27671667BACKGROUND
  • GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.

    PMID: 33069326BACKGROUND
  • Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5.

    PMID: 32024986BACKGROUND
  • Knoery CR, Heaton J, Polson R, Bond R, Iftikhar A, Rjoob K, McGilligan V, Peace A, Leslie SJ. Systematic Review of Clinical Decision Support Systems for Prehospital Acute Coronary Syndrome Identification. Crit Pathw Cardiol. 2020 Sep;19(3):119-125. doi: 10.1097/HPC.0000000000000217.

    PMID: 32209826BACKGROUND
  • Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL, Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L; COBRA-BPS Study Group. A Community-Based Intervention for Managing Hypertension in Rural South Asia. N Engl J Med. 2020 Feb 20;382(8):717-726. doi: 10.1056/NEJMoa1911965.

    PMID: 32074419BACKGROUND
  • Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019 Oct 5;394(10205):1231-1242. doi: 10.1016/S0140-6736(19)31949-X. Epub 2019 Sep 2.

    PMID: 31488369BACKGROUND
  • Peiris D, Praveen D, Mogulluru K, Ameer MA, Raghu A, Li Q, Heritier S, MacMahon S, Prabhakaran D, Clifford GD, Joshi R, Maulik PK, Jan S, Tarassenko L, Patel A. SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India. PLoS One. 2019 Mar 26;14(3):e0213708. doi: 10.1371/journal.pone.0213708. eCollection 2019.

    PMID: 30913216BACKGROUND
  • Neupane D, McLachlan CS, Mishra SR, Olsen MH, Perry HB, Karki A, Kallestrup P. Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial. Lancet Glob Health. 2018 Jan;6(1):e66-e73. doi: 10.1016/S2214-109X(17)30411-4.

    PMID: 29241617BACKGROUND
  • He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, Chen CS, Gibbons L, Krousel-Wood M, Bazzano LA, Nejamis A, Gulayin P, Santero M, Augustovski F, Chen J, Rubinstein A; HCPIA Investigators. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial. JAMA. 2017 Sep 19;318(11):1016-1025. doi: 10.1001/jama.2017.11358.

    PMID: 28975305BACKGROUND
  • Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, Goldstein MK, Hoffman BB, Powers B, Oddone EZ. Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control. Am Heart J. 2007 Jun;153(6):918-24. doi: 10.1016/j.ahj.2007.03.004.

    PMID: 17540191BACKGROUND
  • Mishra SR, Lygidakis C, Neupane D, Gyawali B, Uwizihiwe JP, Virani SS, Kallestrup P, Miranda JJ. Combating non-communicable diseases: potentials and challenges for community health workers in a digital age, a narrative review of the literature. Health Policy Plan. 2019 Feb 1;34(1):55-66. doi: 10.1093/heapol/czy099.

    PMID: 30668690BACKGROUND
  • Morcillo Serra C, Aroca Tanarro A, Cummings CM, Jimenez Fuertes A, Tomas Martinez JF. Impact on the reduction of CO2 emissions due to the use of telemedicine. Sci Rep. 2022 Jul 22;12(1):12507. doi: 10.1038/s41598-022-16864-2.

    PMID: 35869274BACKGROUND
  • Wu S, Li M, Lu J, Tang X, Wang G, Zheng R, Niu J, Chen L, Huo Y, Xu M, Wang T, Zhao Z, Wang S, Lin H, Qin G, Yan L, Wan Q, Chen L, Shi L, Hu R, Su Q, Yu X, Qin Y, Chen G, Gao Z, Shen F, Luo Z, Chen Y, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Li Q, Mu Y, Zhao J, Ning G, Bi Y, Wang W, Xu Y; China Cardiometabolic Disease and Cancer Cohort (4C) Study Groupdagger. Blood Pressure Levels, Cardiovascular Events, and Renal Outcomes in Chronic Kidney Disease Without Antihypertensive Therapy: A Nationwide Population-Based Cohort Study. Hypertension. 2023 Mar;80(3):640-649. doi: 10.1161/HYPERTENSIONAHA.122.19902. Epub 2023 Jan 5.

    PMID: 36601917BACKGROUND
  • Kotruchin P, Mitsungnern T, Ruangsaisong R, Imoun S, Pongchaiyakul C. Hypertensive Urgency Treatment and Outcomes in a Northeast Thai Population: The Results from the Hypertension Registry Program. High Blood Press Cardiovasc Prev. 2018 Sep;25(3):309-315. doi: 10.1007/s40292-018-0272-1. Epub 2018 Jul 26.

    PMID: 30051205BACKGROUND
  • Pierin AMG, Florido CF, Santos JD. Hypertensive crisis: clinical characteristics of patients with hypertensive urgency, emergency and pseudocrisis at a public emergency department. Einstein (Sao Paulo). 2019 Aug 29;17(4):eAO4685. doi: 10.31744/einstein_journal/2019AO4685.

    PMID: 31482942BACKGROUND
  • Shao PJ, Sawe HR, Murray BL, Mfinanga JA, Mwafongo V, Runyon MS. Profile of patients with hypertensive urgency and emergency presenting to an urban emergency department of a tertiary referral hospital in Tanzania. BMC Cardiovasc Disord. 2018 Aug 2;18(1):158. doi: 10.1186/s12872-018-0895-0.

    PMID: 30068315BACKGROUND
  • Masters R, Anwar E, Collins B, Cookson R, Capewell S. Return on investment of public health interventions: a systematic review. J Epidemiol Community Health. 2017 Aug;71(8):827-834. doi: 10.1136/jech-2016-208141. Epub 2017 Mar 29.

    PMID: 28356325BACKGROUND

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Junaid Razzak, MD PhD FACEP

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Junaid A Razzak, MD PhD FACEP

CONTACT

Sheza Hassan, MD MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Randomized Controlled Trial
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Stratified and blocked randomization will be used for individuals meeting enrollment criteria. The randomization will be stratified by gender, and blocked randomization (with varying block sizes) will be used to allocate patients in a 1:1 ratio to either the T-CHW or the referral arm
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 10, 2026

Study Start

March 16, 2026

Primary Completion (Estimated)

August 1, 2029

Study Completion (Estimated)

August 1, 2029

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Anonymized Individual Patient Data (IPD) that underlies results will be submitted in a report format to NIH and published in well-reputed journals.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The data will become available at the end of trial completion when the findings are submitted to National Heart, Lung, and Blood Institute (NHLBI in the form of a detailed report.
Access Criteria
The data will be accessible upon request to the Principal investigator for researchers who intend to learn, adapt, or replicate from our trial findings.

Locations